Novartis seeks quick approval for new cancer drug Glivec

  • 01/03/2001

  • Asian Wall Street Journal (Hong Kong)

Novartis AG has filed for US and European Union approval for its cutting edge cancer therapy Glivec, putting the drug on track to hit the market as early as the third quarter of the year.